valproic acid has been researched along with aminolevulinic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Adamson, AR; Brodie, MJ; Goldberg, A; Herrick, AL; McColl, KE; Moore, MR | 1 |
| Bonkowsky, HL; Emery, S; Sinclair, JF; Sinclair, PR | 1 |
| Belton, RJ; Lawrence, JE; Rovin, RA; Steele, CJ; Winn, RJ | 1 |
| Fukunaga, K; Matsuo, K; Yabuki, Y | 1 |
5 other study(ies) available for valproic acid and aminolevulinic acid
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Ammonia-Lyases; Anticonvulsants; Erythrocytes; Female; Humans; Hydroxymethylbilane Synthase; Male; Middle Aged; Phenytoin; Porphobilinogen; Porphyrias; Valproic Acid | 1989 |
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
Topics: 5-Aminolevulinate Synthetase; Adult; Aminolevulinic Acid; Animals; Benzodiazepinones; Chick Embryo; Clonazepam; Cytochrome P-450 Enzyme System; Hemin; Humans; Liver Diseases; Male; Porphobilinogen; Porphyrias; Rats; Seizures; Valproic Acid | 1980 |
Dexamethasone alone and in combination with desipramine, phenytoin, valproic acid or levetiracetam interferes with 5-ALA-mediated PpIX production and cellular retention in glioblastoma cells.
Topics: Aminolevulinic Acid; Anti-Inflammatory Agents; Anticonvulsants; Desipramine; Dexamethasone; Drug Therapy, Combination; Enzyme Inhibitors; Fluorescence; Glioblastoma; Humans; Levetiracetam; Phenytoin; Photosensitizing Agents; Piracetam; Protoporphyrins; Valproic Acid | 2016 |
5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
Topics: Aminolevulinic Acid; Animals; Anticonvulsants; Autistic Disorder; Dose-Response Relationship, Drug; Drug Repositioning; Exploratory Behavior; Female; Male; Maze Learning; Oxidative Stress; Photosensitizing Agents; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Valproic Acid | 2020 |